Fredrick Hagemeister

Fredrick Hagemeister

UNVERIFIED PROFILE

Are you Fredrick Hagemeister?   Register this Author

Register author
Fredrick Hagemeister

Fredrick Hagemeister

Publications by authors named "Fredrick Hagemeister"

Are you Fredrick Hagemeister?   Register this Author

100Publications

2552Reads

41Profile Views

CD5+ diffuse large B-cell lymphoma, NOS: clinical characteristics and outcomes in rituximab era.

Leuk Lymphoma 2019 Sep 18:1-9. Epub 2019 Sep 18.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1663418DOI Listing
September 2019

Rosai-Dorfman Disease: The MD Anderson Cancer Center Experience.

Clin Lymphoma Myeloma Leuk 2019 Jul 4. Epub 2019 Jul 4.

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.06.013DOI Listing
July 2019

Prevalence of a Histologic Change of Ocular Adnexal Lymphoma in Patients With a History of Lymphoma.

Ophthalmic Plast Reconstr Surg 2018 Aug 17. Epub 2018 Aug 17.

Orbital Oncology and Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IOP.0000000000001215DOI Listing
August 2018

Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With R-CHOP.

Clin Lymphoma Myeloma Leuk 2018 01 14;18(1):e103-e108. Epub 2017 Nov 14.

Department of Lymphoma and Myeloma, The University of Texas, M.D. Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.11.001DOI Listing
January 2018

Dose-Adjusted EPOCH-R and Mid-Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement.

Br J Haematol 2017 12 9;179(5):851-854. Epub 2016 Aug 9.

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14267DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063086PMC
December 2017

Rates of Positive Findings on Positron Emission Tomography and Bone Marrow Biopsy in Patients With Ocular Adnexal Lymphoma.

Ophthalmic Plast Reconstr Surg 2017 Sep/Oct;33(5):355-360

*Orbital Oncology and Ophthalmic Plastic Surgery, Department of Plastic Surgery, †Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, ‡Department of Ophthalmology and Visual Sciences, The University of Texas Medical Branch, Galveston, Texas, U.S.A.; §Narayana Nethralaya, Narayana Health City, Bangalore, India; ‖Department of Lymphoma and Myeloma, ¶Department of Radiation Oncology, and #Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IOP.0000000000000789DOI Listing
September 2017

Targeted therapies for Hodgkin lymphoma: results of recent trials.

Rinsho Ketsueki 2016;57(10):2049-2053

Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.11406/rinketsu.57.2049DOI Listing
February 2017

Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin lymphoma.

Haematologica 2015 Jul 27;100(7):e272-4. Epub 2015 Mar 27.

Department of Lymphoma and Myeloma, University of Texas, MD Anderson Cancer Center, Houston, TX 77030 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2015.126557DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486240PMC
July 2015

Phase I study of panobinostat plus everolimus in patients with relapsed or refractory lymphoma.

Clin Cancer Res 2013 Dec 4;19(24):6882-90. Epub 2013 Oct 4.

Authors' Affiliations: Departments of Lymphoma/Myeloma, Diagnostic Imaging, and Biostatistics, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1906DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409814PMC
December 2013

R-CHOP every 21 days for diffuse large B-cell lymphoma: still the standard of care?

J Comp Eff Res 2013 Nov;2(6):537-40

MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cer.13.76DOI Listing
November 2013

A phase 2 study of epothilone B analog BMS-247550 (NSC 710428) in patients with relapsed aggressive non-Hodgkin lymphomas.

Cancer 2013 May 10;119(9):1683-9. Epub 2013 Jan 10.

Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.27917
Publisher Site
http://dx.doi.org/10.1002/cncr.27917DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332882PMC
May 2013

'Watch and wait' as initial management for patients with follicular lymphomas: still a viable strategy?

BioDrugs 2012 Dec;26(6):363-76

MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/11634320-000000000-00000DOI Listing
December 2012

Maintenance and consolidation strategies in non-Hodgkin's lymphoma: A review of the data.

Curr Oncol Rep 2010 Nov;12(6):395-401

Department of Lymphoma/Myeloma, M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-010-0128-xDOI Listing
November 2010

Incidence and risk factors of venous thromboembolic events in lymphoma.

Am J Med 2010 Oct;123(10):935-41

Department of Sarcoma Medical Oncology, Section of Cytokines & Supportive Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2010.05.021DOI Listing
October 2010

Rituximab for the treatment of non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.

Drugs 2010 Feb;70(3):261-72

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.2165/11532180-000000
Web Search
http://link.springer.com/10.2165/11532180-000000000-00000
Publisher Site
http://dx.doi.org/10.2165/11532180-000000000-00000DOI Listing
February 2010

Bendamustine in the treatment of non-Hodgkin's lymphomas.

Onco Targets Ther 2009 Feb 18;2:269-79. Epub 2009 Feb 18.

Department of Lymphoma/Myeloma, The University of Texas M.D. Anderson Cancer Center Houston, TX, USA;

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886317PMC
February 2009

Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma.

Cancer 2008 Feb;112(4):831-6

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.23237
Publisher Site
http://dx.doi.org/10.1002/cncr.23237DOI Listing
February 2008

Follicular dendritic cell sarcoma: a report of 14 cases and a review of the literature.

Am J Hematol 2007 Aug;82(8):725-8

Department of Lymphoma and Myeloma, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.20852DOI Listing
August 2007

Combination treatment approaches and novel therapies for lymphoma.

Clin Adv Hematol Oncol 2007 Aug;5(8 Suppl 12):4-20; quiz 1 p following 20

View Article

Download full-text PDF

Source
August 2007

Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma.

Cancer 2007 Jun;109(12):2481-9

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.22714
Publisher Site
http://dx.doi.org/10.1002/cncr.22714DOI Listing
June 2007

Treatment of the patient with diffuse large B-cell lymphoma with medical co-morbidities: newer therapies needed.

Leuk Lymphoma 2007 Apr;48(4):657-8

Department of Lymphoma and Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190701286504DOI Listing
April 2007

Hodgkin's lymphoma in younger patients: lessons learned on the road to success.

Oncology (Williston Park) 2007 Apr;21(4):434-40; discussion 441-2, 445-6

Department of Hematology, The University of Texas M.D. Anderson Cancer Center Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
April 2007

Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma.

J Infect Dis 2006 Nov 6;194(10):1394-7. Epub 2006 Oct 6.

Department of Infectious Diseases, Infection Control, and Employee Health, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/508493DOI Listing
November 2006

Hodgkin transformation of chronic lymphocytic leukemia: the M. D. Anderson Cancer Center experience.

Cancer 2006 Sep;107(6):1294-302

Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22121DOI Listing
September 2006

Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphoma.

Leuk Lymphoma 2006 Sep;47(9):1818-21

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190600684999DOI Listing
September 2006

Acral necrotizing mycosis fungoides.

Clin Lymphoma Myeloma 2005 Sep;6(2):146-8

Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S155791901170384
Publisher Site
http://dx.doi.org/10.3816/CLM.2005.n.043DOI Listing
September 2005

Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma.

Cancer 2005 Aug;104(4):781-7

Department of Lymphoma/Myeloma, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.21219DOI Listing
August 2005

Stem-cell transplant for Hodgkin's lymphoma: does choice of therapy prior to high-dose treatment matter?

Nat Clin Pract Oncol 2005 Jul;2(7):344-5

Department of Lymphoma and Myeloma, University of Texas, MD Anderson Cancer Center, Houston 77030, USA.

View Article

Download full-text PDF

Source
July 2005

The status of allopurinol in the management of tumor lysis syndrome: a clinical review.

Cancer J 2005 Jan-Feb;11 Suppl 1:S1-10

Department of Lymphoma, MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
June 2005

The role of mitoxantrone in the treatment of indolent lymphomas.

Oncologist 2005 Feb;10(2):150-9

The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.10-2-150DOI Listing
February 2005

Lymphoma of the colon.

Curr Opin Gastroenterol 2005 Jan;21(1):80-4

University of Texas, MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
January 2005

Phase II study of denileukin diftitox for relapsed/refractory B-Cell non-Hodgkin's lymphoma.

J Clin Oncol 2004 Oct 7;22(20):4095-102. Epub 2004 Sep 7.

The University of Texas M.D. Anderson Cancer Center, Department of Lymphoma/Myeloma, 1515 Holcombe Blvd, Box 429, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2004.03.071DOI Listing
October 2004

Bone marrow involvement in patients with nodular lymphocyte predominant Hodgkin lymphoma.

Am J Surg Pathol 2004 Apr;28(4):489-95

Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00000478-200404000-00008DOI Listing
April 2004

Thalidomide for patients with recurrent lymphoma.

Cancer 2004 Mar;100(6):1186-9

Department of Lymphoma/Myeloma, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20070DOI Listing
March 2004

Second malignancies after chemotherapy and radiotherapy for Hodgkin disease.

Am J Clin Oncol 2004 Feb;27(1):73-80

Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.coc.0000045853.73233.42DOI Listing
February 2004

Radiotherapy alone for lymphocyte-predominant Hodgkin's disease.

Cancer J 2002 Sep-Oct;8(5):377-83

Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston 77030-4009, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/journalppo/2002/09000/Radiother
Web Search
April 2003

Rituximab and chemotherapy for aggressive lymphomas: a significant advance in therapy.

Clin Adv Hematol Oncol 2003 Feb;1(2):120-5

Department of Lymphoma/Myeloma, Univeristy of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
February 2003

NOVP chemotherapy for Hodgkin's disease transiently induces sperm aneuploidies associated with the major clinical aneuploidy syndromes involving chromosomes X, Y, 18, and 21.

Cancer Res 2003 Jan;63(1):44-51

Biology and Biotechnology Research Program, Lawrence Livermore National Laboratory, Livermore, California 94550, USA.

View Article

Download full-text PDF

Source
January 2003

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Cancer Chemother Pharmacol 2002 May 12;49 Suppl 1:S13-20. Epub 2002 Apr 12.

Department of Lymphoma/Myeloma, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Box 429, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-002-0447-1DOI Listing
May 2002